Please use symbol entry at top right of page to search

With 20.1% CAGR, Gene Panel Market Size to Worth Around USD 8157.6 Million by 2028, Says Brandessence Market Research

LONDON, Aug. 3, 2022 /PRNewswire/ -- Gene Panel Market was valued at USD 2263.4 Million in 2021 and expected to reach USD 8157.6 Million by 2028 with the CAGR of 20.1% over the forecast period.


The growing prevalence of chronic diseases, the growing number of product launches, and the growing demand for advanced medical testing are key factors expected to drive the Global Gene Panel Market.

Gene Panel Market: Market Scope

The global gene panel market has been showing continuous growth in the last few years in its numbers owing to the increase in the number of company initiatives which have been taken up all over the world. These have been the major factors which are fostering the growth of the market. There has also been an increase in the genetic testing adoption as well as the advancements in technology and a need for the prenatal diagnosis are a few of the other factors which fuel the market growth.

Get Sample of Report at:

A gene panel refers to a test which examines many genes at one for the cancer-associated mutations. The gene panels also provide a mid-way between sequencing only a particular gene such as the BRCA1 which is involved in the risk of a disease and sequencing every gene which is in the genome. This is a focused approach which enables the capturing of only the relevant information. A set of gene mutations which are less known but equally significant cause the Lynch Syndrome and also put the people at a higher risk for the colon, stomach, ovarian and endometrial and many other cancers which do not have the syndrome. The prevailing panel tests have the ability to decide for this and the other syndromes which are less common.

Apart from this, the targeted gene sequencing panels also become a powerful tool of analyzing any particular mutation in any given sample. The focused panels also contain a set of genes or the gene regions which are identified or the suspected associations with phenotypes or diseases. The gene panels may be bought with the pre-selected content or can be custom-made for covering the genomic interest regions.

Gene Panel Market: Segmentation Analysis

In terms of segmentation based on design, the market has been led by the predesigned gene panel market. It is expected that the market will also see the greatest growth in the coming years as it concentrates on the genes which are most expected to get involved. The panels help in the saving of resources and also minimize the considerations for the data analysis. The predesigned panels also are convenient for the research on different diseases that can include cardiac conditions, autism, cancer and inherited disorders

On the basis of application, the market has been led by the cancer risk assessment and that segment will also show the greatest amount of growth in the coming years. the identification of the individuals with the suspect heritable cancer may lead to the additional evaluation and also formulate the prevention and also the strategies of treatment. There are government guidelines which also support the growth of the segment.

By Technique 

  • Amplicon-based approach
  • Hybridization-based approach

By Products & Services 

  • Test Kits
  • Testing Services

By Design

  • Predesigned Gene Panels
  • Customized Gene Panels

By Application 

  • Cancer Risk Assessment
  • Diagnosis of Congenital Disorders
  • Pharmacogenetics
  • Others

By End Users

  • Hospital and Diagnostic Laboratories
  • Research Institutes
  • Biotechnology and Pharmaceutical Companies

Buy this report now:

Gene Panel Market: Competitive Analysis 

Some of the major gene panel companies 2021 are the companies such as BGI, Integrated DNA Technologies, Thermo Fisher Scientific Inc, Genewiz, Inc., Qiagen Novogene Corporation, and others. The global gene panel key players are working on innovation and ease of conducting these tests. They are now working to make the analysis of the test a lot more specific.

  • Agilent Technologies
  • Themo Fischer Scientific
  • GeneDx Inc
  • Eurofins Scientific
  • Illumina Inc.
  • Novogene Co., Ltd.
  • GATC Biotech
  • Invitae Corporation
  • Novogene Co., Ltd.

Gene Panel Market: Key Drivers

Gene panel growth drivers include the applications that exist in the market. The gene panels get used in the treatments and diagnostic for the illnesses such as cancer. The cancer risk assessment, syndrome-specific diagnostics, diseases penetration and some other applications are the common ones in the gene panels. On basis of the researches by World Health Organizations, the contribution of the diseases is expected to rise in all the deaths and global disease burden. The demand for the gene panels is further going to be enhanced over the coming years with the prevalence of the chronic obstructive pulmonary diseases as well as diabetes.

This is going to upsurge the demand ultimately for the gene panels over the coming years. The diagnostic of the breast cancer and tests related to it are also seeing an increase considering the prevalence of breast cancer in women. Apart from this, a single test provides a lot more information about women being suspect to the hereditary predisposition for the ovarian and breast cancer. Apart form this, in a comparison of tests, there is no difference between this test known as the BRCA ½ test and the other tests

Get Methodology at

Gene Panel Market: Key Trends

Gene panel trends suggest that the major challenge is going to be the protection of data. The genetic data is the data which is most personal for any individual. Furthermore, it is also an ultimate unique identifier of every single living being. Apart from this, the information breaches with regard this cannot be retrieved because it is not akin to the other website or the banking passwords which might be changed over a span of time. The gene data for every single living thing all over the world is unique and also may not be changed across a lifetime. This may also restrict the use of the gene testing all over the research and development and the healthcare sector.

Because this data has so much value, it also offers the incentives to the hackers for targeting the genetic databases for acquiring the data which can be used for an identity or financial fraud. The development of the research institutes privately as well as the support of government in strengthening the research has ultimately created multiple opportunities in the market. Gene panel 2022 therefore looks like a market which will see continuous growth.

Gene Panel Market: Regional Analysis

Gene panel statistics suggest that the North American region will be accounting for the biggest share in the market and it is going to grow at the greatest growth rate in the coming years. The consumers demand the safe and effective tests which is going to fuel the growth in the global gene panel market. However, it is the growth in the demand for the personalized medicine and the growth in the application in oncology testing which will fuel the growth. A rise in the geriatric population is also increasing the market growth.

On Special Requirement Gene Panel Market Report is also available for below region:

North America

  • U.S., Canada


  • Germany, France, U.K., Italy, Spain, Sweden, Netherlands, Turkey, Switzerland, Belgium, Rest of Europe


  • South_Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC

Latin America

  • Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

  • Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA

Get Full Access of all Report:

Related Reports: 

  • DNA Data Storage Market is expected to reach USD 1926.7 Million by 2028 | CAGR 65.8%
  • Self–Testing Market is expected to reach USD 8.11 Billion by 2027 | CAGR 4.50%
  • eClinical Solution Market is expected to reach USD 19.69 Million by 2028 | CAGR 13.5%
  • Healthcare CRM Market is expected to reach USD 31.54 Billion by 2028 | CAGR 14.1%
  • Health Facilities Management Market is expected to reach USD 436.48 Billion by 2025 | CAGR 12.68%
  • Oral Care Market Size, Share, Companies & Trends Analysis Report By Product (Toothpaste, Toothbrushes, Manual Toothbrushes, Electronic Toothbrushes, Mouthwashes/Rinses, Dental Accessories) Based On Industry Region, And Segment Forecasts, 2022 – 2028
  • Cancer Supportive Care Drugs Market is expected to reach USD 23.79 Billion by 2028
  • DNA Sequencing Market is expected to reach USD 10944.1 Million by 2027 | CAGR 11.5%
  • Tissue Engineering Market is expected to reach USD 28.47 Billion by 2025 with a CAGR of 15.74%

i-Factor: Live Market intelligence platform

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at

Brandessence Market Research & Consulting Pvt ltd.

Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Follow Us: Linkedin 

Mr. Vishal Sawant 
Corporate Sales: +44-2038074155 
Asia Office: +917447409162


Cision View original content:

SOURCE Brandessence Market Research and Consulting Private Limited

Search News

Filter Results

Publication Date
  • All

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.